UnknownNot Applicable

Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision

Israel40 participantsStarted 2009-06

Plain-language summary

The purpose of this study is to determine whether there is a difference in corneal epithelial healing rate and/or toxicity following pterygium excision, between eyes treated post-operatively by moxifloxacin(VIGAMOX)versus gatifloxacin (ZYMAR).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. diagnosis of primary pterygium with a clinical indication for surgery
✓. informed consent

Exclusion criteria

✕. known allergic reaction to fluoroquinolones.
✕. secondary\\recurrent pterygium or clinical suspected conjunctival tumor.
✕. eye surgery in the last 6 months.
✕. eye disorders: severe dry eye syndrome, ocular surface diseases, glaucoma, recurrent corneal erosions, chronic corneal diseases, after chemical burn.
✕. low compliance.
✕. pregnancy

What they're measuring

rate of corneal epithelial defect closure

Timeframe: 21 days

Trial details

NCT IDNCT00892918

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-06

Contact for this trial

Fani Segev, MD

972-52-6995044 fsegev@netvision.net.il

View on ClinicalTrials.gov More Primary Pterygium trials